Business Context and Reporting Period
This Form 6-K filing by InflaRx N.V. reports the results of the Annual General Meeting of Shareholders held on May 23, 2019. The meeting addressed corporate governance matters, including the approval of statutory accounts for the fiscal year ended December 31, 2018, and the appointment of new directors.
Key Financial Metrics
The filing text does not provide specific financial values for revenue, profit, cash flow, margins, debt, or liquidity. It confirms only that shareholders approved the adoption of the Dutch statutory annual accounts for the fiscal year ended December 31, 2018.
Material Changes
No material financial changes or operational updates are detailed in this document. The primary changes reported are corporate governance actions approved by shareholders, including the appointment of Mr. Richard Brudnick as a non-executive director and the extension of board authorizations regarding share issuance and buybacks.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook for future periods. It does not disclose specific risks, contingencies, or unusual items beyond the standard corporate resolutions passed at the meeting.
Key Facts for Investor Verification
- Shareholders approved the Dutch statutory annual accounts for the fiscal year ended December 31, 2018.
- KPMG Accountants N.V. was instructed to perform the external audit for the 2019 financial year.
- Mr. Richard Brudnick was appointed as a non-executive director.
- The Board received extended authorization to issue shares, grant subscription rights, limit pre-emption rights, and acquire company shares.
- Directors were released from liability regarding their duties during the fiscal year ended December 31, 2018.